BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6186298)

  • 1. Autoimmune model of schizophrenia with special reference to antibrain antibodies.
    Pandey RS; Gupta AK; Chaturvedi UC
    Biol Psychiatry; 1981 Dec; 16(12):1123-36. PubMed ID: 6186298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The neurotropic and autoimmune activity of the serum of patients with psychoses of old age and patients with schizophrenia].
    Solntseva EI; Kushner SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(8):1228-31. PubMed ID: 1217418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of the reaction of complement consumption for detection of antibrain autoantibodies].
    Kogan RD; Trekova NA
    Lab Delo; 1976; (3):161-4. PubMed ID: 58124
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-somatostatin autoantibodies in the blood serum of patients with schizophrenia].
    Rogaeva EA; Chumakova MM; Dergunova NN; Pozharitskaia DA; Kopeĭko GI; Tsutsul'kovskaia MIa; Tsibezov VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):82-4. PubMed ID: 1979460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brain antibodies in schizophrenia].
    Henneberg A; Ruffert S; Horter S; Kornhuber HH
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):583-6. PubMed ID: 7856265
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indirect immunofluorescence and complement absorption test characterization of anti-brain antibodies in schizophrenia].
    Mogilina NP; Zhirnova IG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):397-401. PubMed ID: 7020298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study of the complement fixation test and the hemagglutination test for detecting anti-brain antibodies in the sera of schizophrenic patients].
    Glebev VS; Zilbershteĭn AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(1):82-7. PubMed ID: 1119247
    [No Abstract]   [Full Text] [Related]  

  • 8. Myelin basic protein antibodies in catatonic schizophrenia.
    Rimón R; Ahokas A; Ruutiainen J; Halonen P
    J Clin Psychiatry; 1986 Jan; 47(1):26-8. PubMed ID: 2416737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to thymocytes in sera of normal controls and of patients with schizophrenia.
    Singal DP; Grof P; MacCrimmon D
    J Immunol; 1975 Apr; 114(4):1425-7. PubMed ID: 1078837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects of humoral and cellular immunity in schizophrenia.
    Vartanian ME; Kolyaskina GI; Lozovsky DV; Burbaeva GS; Ignatov SA
    Birth Defects Orig Artic Ser; 1978; 14(5):339-64. PubMed ID: 80239
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased prevalence of antibrain antibodies in the sera from schizophrenic patients.
    Henneberg AE; Horter S; Ruffert S
    Schizophr Res; 1994 Dec; 14(1):15-22. PubMed ID: 7893617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The succession if immunization of schizophrenic patients by brain antigens during periods of exacerbation of the schizophrenic process].
    Glebov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):596-600. PubMed ID: 5497115
    [No Abstract]   [Full Text] [Related]  

  • 13. Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients--part II: adult subjects.
    Spivak B; Schechtman M; Schonherz-Pine Y; Blumensohn R; Mostovoy S; Amital D; Deckmann M; Weizman A; Shinitzky M
    Neuropsychobiology; 2009; 60(1):49-54. PubMed ID: 19729973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incomplete anti-tissue autoantibodies in schizophrenia].
    Gurevich ZP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(11):1683-7. PubMed ID: 5369970
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibrain antibodies in alcoholic patients.
    Henneberg AE; Böger P; Sahnwaldt F; Dumke HO; Kornhuber HH
    Alcohol Alcohol; 1993 Mar; 28(2):181-7. PubMed ID: 8517889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithymic antibodies in schizophrenic sera.
    Watanabe M; Funahashi T; Suzuki T; Nomura S; Nakazawa T; Noguchi T; Tsukada Y
    Biol Psychiatry; 1982 Jun; 17(6):699-710. PubMed ID: 6125218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antithymic factor in schizophrenia patients].
    Koliaskina GI; Tsutsul'kovskaia MIa; Domashneva IV; Maznina TP; Kil'gol'ts P
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):710-6. PubMed ID: 6968137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural autoantibodies in schizophrenia.
    Galinowski A; Barbouche R; Truffinet P; Louzir H; Poirier MF; Bouvet O; Loo H; Avrameas S
    Acta Psychiatr Scand; 1992 Mar; 85(3):240-2. PubMed ID: 1561897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On a study of the autoimmune processes associated with brain pathology at various stages in the course of schizophrenia].
    Semenov SF; Glebov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(1):87-92. PubMed ID: 5771497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.